Federal Register / Vol. 83, No. 147 / Tuesday, July 31, 2018 / Notices 36943 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, NIH 

9609, Medical Center Drive, Room 7W248, 

Bethesda, MD 20892–9750, 240–276–5007 

tandlea@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; NCI 

Program Project III (P01). 

Date: September 24–25, 2018. 

Time: 8:00 a.m. to 12:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Washington/Rockville Hotel, 

1750 Rockville Pike, Rockville, MD 20852. 

Contact Person: Majed M. Hamawy, Ph.D., 

Scientific Review Officer, Research Program 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, NIH 

9609, Medical Center Drive, Room 7W120, 

Bethesda, MD 20892–9750, 240–276–6457, 

mh101v@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; NCI 

Program Project V (P01). 

Date: September 24–25, 2018. 

Time: 4:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Gaithersburg Marriott 

Washingtonian Center, 9751 Washingtonian 

Boulevard, Gaithersburg, MD 20878. 

Contact Person: Adriana Stoica, Ph.D., 

Scientific Review Officer, Resources and 

Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH 9609, Medical Center Drive, 

Room 7W234, Bethesda, MD 20892–9750, 

240–276–6368, Stoicaa2@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Initial Review Group, Subcommittee 

F—Institutional Training and Education. 

Date: October 15–16, 2018. 

Time: 7:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard Bethesda, MD 20817. 

Contact Person: Timothy C. Meeker, M.D., 

Scientific Review Officer, Resources and 

Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH 9609, Medical Center Drive, 

Room 7W624, Bethesda, MD 20892–9750, 

240–276–6464, meekert@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Informatics 

Technologies for Cancer Research. 

Date: October 24–25, 2018. 

Time: 5:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda North Marriott Hotel & 

Conference Center, 5701 Marinelli Road, 

North Bethesda, MD 20852. 

Contact Person: Nadeem Khan, Ph.D., 

Scientific Review Officer, Research 

Technology and Contract Review Branch, 

Division of Extramural Activities, National 

Cancer Institute, NIH 9609, Medical Center 

Drive, Room 7W260, Bethesda, MD 20892– 

9750, 240–276–5856, nadeem.khan@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Innovative 

Molecular Analysis Technologies. 

Date: November 7, 2018. 

Time: 10:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute, Shady 

Grove, 9609 Medical Center Drive, Room 

7W246, Rockville, MD 20850 (Telephone 

Conference Call). 

Contact Person: Jun Fang, Ph.D., Scientific 

Review Officer, Research Technology and 

Contract Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH 9609, Medical Center Drive, 

Room 7W246, Bethesda, MD 20892–9750, 

240–276–5460, jfang@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; IMAT 

Biospecimen Research. 

Date: November 14, 2018. 

Time: 10:00 a.m. to 1:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute, Shady 

Grove, 9609 Medical Center Drive, Room 

7W246, Rockville, MD 20850 (Telephone 

Conference Call). 

Contact Person: Jun Fang, Ph.D. Scientific 

Review Officer, Research Technology and 

Contract Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH 9609, Medical Center Drive, 

Room 7W246, Bethesda, MD 20892–9750, 

240–276–5460 jfang@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: July 25, 2018. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–16291 Filed 7–30–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Fogarty International Center; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the Fogarty International 

Center Advisory Board. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications 

and/or contract proposals and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications and/or contract proposals, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Fogarty International 

Center Advisory Board. 

Date: September 6–7, 2018. 

Closed: September 6, 2018, 3:00 p.m. to 

5:00 p.m. 

Agenda: Second level review of grant 

applications. 

Place: National Institutes of Health, 

Lawton L. Chiles International House 

Building 16, Conference Room, 16 Center 

Drive, Bethesda, MD 20892. 

Open: September 7, 2018, 9:00 a.m. to 3:00 

p.m. 

Agenda: Update and discussion of current 

and planned FIC activities. 

Place: National Institutes of Health, 

Lawton L. Chiles International House, 

Building 16, Conference Room, 16 Center 

Drive, Bethesda, MD 20892. 

Contact Person: Kristen Weymouth, 

Executive Secretary, Fogarty International 

Center, National Institutes of Health, 31 

Center Drive, Room B2C02, Bethesda, MD 

20892, (301) 496–1415, weymouthk@

mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the 

Institute’s/Center’s home page: http://

www.fic.nih.gov/About/Advisory/Pages/ 

default.aspx, where an agenda and any 

additional information for the meeting will 

be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.106, Minority International 

Research Training Grant in the Biomedical 

and Behavioral Sciences; 93.154, Special 

International Postdoctoral Research Program 

in Acquired Immunodeficiency Syndrome; 

93.168, International Cooperative 

Biodiversity Groups Program; 93.934, Fogarty 

International Research Collaboration Award; 

93.989, Senior International Fellowship 


daltland on DSKBBV9HB2PROD with NOTICES
36944 Federal Register / Vol. 83, No. 147 / Tuesday, July 31, 2018 / Notices 

Awards Program, National Institutes of 

Health, HHS) 

Dated: July 25, 2018. 

Natasha M. Copeland, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–16299 Filed 7–30–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Heart, Lung, 

and Blood Advisory Council. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Heart, Lung, 

and Blood Advisory Council. 

Date: August 28, 2018. 

Time: 1:00 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Room 9100, Bethesda, MD 

20892 (Teleconference). 

Contact Person: Laura K. Moen, Ph.D., 

Director, Division of Extramural Research 

Activities, National Heart, Lung, and Blood 

Institute, National Institutes of Health, 6701 

Rockledge Drive, Room 7100, Bethesda, MD 

20892, 301–435–0260, moenl@mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Center’s home page: 

www.nhlbi.nih.gov/meetings/nhlbac/ 

index.htm, where an agenda and any 

additional information for the meeting will 

be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 

Dated: July 25, 2018. 

David D. Clary, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–16293 Filed 7–30–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Eunice Kennedy Shriver National 

Institute of Child Health & Human 

Development; Notice of Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Advisory Child 

Health and Human Development 

Council. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. A 

portion of this meeting will be closed to 

the public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended for the review and 

discussion of grant applications. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the contact person listed below in 

advance of the meeting. 

Name of Committee: National Advisory 

Child Health and Human Development 

Council. 

Date: September 13, 2018–September 14, 

2018. 

Open: September 13, 2018. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: The agenda will include opening 

remarks, administrative matters, Director’s 

Report, Division of Extramural Research 

Report and other business of the Council. 

Place: National Institutes of Health, 6710B 

Bethesda Drive, Rm. 1425, Bethesda, MD 

20892. 

Closed: September 14, 2018. 

Time: 8:00 a.m. to Adjournment. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6710B 

Bethesda Drive, Rm. 1425, Bethesda, MD 

20892. 

Contact Person: Della Hann, Ph.D., 

Director, Division of Extramural Research, 

Eunice Kenney Shriver National Institute of 

Child Health, and Human Development, NIH, 

6710 Rockledge Blvd., MSC 7002, Bethesda, 

MD 20892, 301–496–8535. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the contact person listed on 

this notice. The statement should include the 

name, address, telephone number, and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxis, hotel, and airport shuttles, 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. In order to facilitate public attendance 

at the open session of Council in the main 

meeting room, Conference Room 1425, please 

contact Ms. Lisa Kaeser, Office of Legislation 

and Public Policy, NICHD, at 301–496–0536 

to make your reservation, additional seating 

will be available in the meeting overflow 

rooms, Conference Rooms 1417 and 1411. 

Individuals will also be able to view the 

meeting via NIH Videocast. Select the 

following link for Videocast access 

instructions: http://www.nichd.nih.gov/ 

about/advisory/nachhd/Pages/virtualmeeting.aspx. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment program, National 

Institutes of Health, HHS) 

Dated: July 25, 2018. 

David D. Clary, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–16295 Filed 7–30–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The purpose of this 

meeting is to evaluate requests for 

preclinical development resources for 

potential new therapeutics for the 

treatment of cancer. The outcome of the 

evaluation will provide information to 

internal NCI committees that will 

decide whether NCI should support 

requests and make available contract 

resources for development of the 

potential therapeutic to improve the 

treatment of various forms of cancer. 

The research proposals and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the 


daltland on DSKBBV9HB2PROD with NOTICES